About: Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Latest price: $50.44 (-3.46%)
PLSE NASDAQ Pulse Biosciences Inc
Pulse Biosciences Inc share price
Atividade de preço de PLSE
Último preço
$ 50,440
Variação (24h)
-1,81 USD (3,46%)
Volume
589.84K
Volume (média 4 sem.)
-
Abertura
$ 52,53
Variação do dia
$ 50,33 - $ 54,25
Fechamento anterior
$ 52,25
Último negócio
13 Nov, 9:00 pm GMT+0
Atrasado
13 Nov, 9:00 pm GMT+0
PLSE price performance
Atrasado
13 Nov, 9:00 pm GMT+0
PLSE details
quote.marketSignals